Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas.

× No keyword cloud information.

19 in total

1. Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients?

Authors: Nuggehally R Srinivas
Journal: Clin Drug Investig Date: 2017-09 Impact factor: 2.859

Review 2. Euglycaemic glucose clamp: what it can and cannot do, and how to do it.

Authors: Tim Heise; Eric Zijlstra; Leszek Nosek; Sascha Heckermann; Leona Plum-Mörschel; Thomas Forst
Journal: Diabetes Obes Metab Date: 2016-07-13 Impact factor: 6.577

3. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

Authors: S R Mudaliar; F A Lindberg; M Joyce; P Beerdsen; P Strange; A Lin; R R Henry
Journal: Diabetes Care Date: 1999-09 Impact factor: 19.112

4. Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels.

Authors: H Süsstrunk; B Morell; W H Ziegler; E R Froesch
Journal: Diabetologia Date: 1982-03 Impact factor: 10.122

5. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.

Authors: J P Bantle; L Neal; L M Frankamp
Journal: Diabetes Care Date: 1993-12 Impact factor: 19.112

6. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen.

Authors: J E Henriksen; M S Djurhuus; A Vaag; P Thye-Rønn; D Knudsen; O Hother-Nielsen; H Beck-Nielsen
Journal: Diabetologia Date: 1993-08 Impact factor: 10.122

Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas.

1. Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients?

Review 2. Euglycaemic glucose clamp: what it can and cannot do, and how to do it.

3. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

4. Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels.

5. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.

6. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen.

7. The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back.

8. The effect of subcutaneous injection site on absorption of human growth hormone: abdomen versus thigh.

9. Glucose-lowering effect of insulin degludec is independent of subcutaneous injection region.

Review 10. A review of the pharmacological properties of insulin degludec and their clinical relevance.